TC BioPharm Faces Nasdaq Exit: What This OTC Markets Move Means for Investors - Stock Titan
2025-03-21 • Google News
TC BioPharm Holdings PLC (TCBP)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 256.5K
P/E Ratio
0.00
Revenue (TTM)
$ 2.86M
Volume
0
52W High
$ 150.88
52W Low
$ 0.50
Dividend Yield
0.00%
Beta
0.01
Technicals
50-Day MA
1.9068
200-Day MA
41.5609
52 Week High
150.88
52 Week Low
0.5
About TCBP
TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on the development of immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline i.
Employees
41
Headquarters
Motherwell, United Kingdom
CEO
Mr. Bryan Leland Kobel